STERIS plc (STE) stock
STENYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 19/300% above fair value
$259.57+2.16 (+0.84%)
Close on Nov 18, 2026Market cap $25.31BP/E 31.7Yield 0.95%
Steris gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Steris's gross profit for the twelve months ending Jun 30, 2026 was $2.68B, up 9.1% year over year. For fiscal 2026 it was $2.63B, up 9.3% from the year before. The highest annual figure on record is $2.63B in fiscal 2026.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $2.63B | +9.3% |
| FY2025 | Mar 31, 2025 | $2.40B | +8.3% |
| FY2024 | Mar 31, 2024 | $2.22B | +12.0% |
| FY2023 | Mar 31, 2023 | $1.98B | +5.2% |
| FY2022 | Mar 31, 2022 | $1.88B | +40.2% |
| FY2021 | Mar 31, 2021 | $1.34B | +1.8% |
| FY2020 | Mar 31, 2020 | $1.32B | +12.3% |
| FY2019 | Mar 31, 2019 | $1.17B | +7.5% |
| FY2018 | Mar 31, 2018 | $1.09B | +6.5% |
| FY2017 | Mar 31, 2017 | $1.03B | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $684.20M | +8.9% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $697.10M | +8.7% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $655.50M | +7.4% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $645.90M | +11.6% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $628.00M | +9.7% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $641.20M | +10.0% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $610.30M | +9.0% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $578.80M | +6.0% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $572.40M | +8.2% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $582.90M | +6.7% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $560.03M | +17.1% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $546.23M | +13.3% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $529.00M | +11.6% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $546.40M | -4.4% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $478.19M | -11.1% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $482.31M | +0.4% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $473.83M | +11.2% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $571.62M | +50.5% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $538.11M | +55.6% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $480.34M | +45.5% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $426.28M | +48.3% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $379.82M | +4.6% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $345.86M | +4.4% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $330.04M | +3.6% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $287.38M | -6.4% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $363.09M | +8.5% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $331.35M | +15.5% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $318.67M | +11.9% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $306.89M | +14.1% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $334.72M | +14.5% |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $287.00M | +3.2% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $284.66M | +2577.7% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $269.05M | +5.2% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $292.37M | – |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $278.22M | – |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $10.63M | – |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $255.77M | – |
See a number that looks wrong?